When is the absence of evidence, evidence of absence? Use of equivalence-based analyses in genetic epidemiology and a conclusion for the KIF1B rs10492972*C allelic association in multiple sclerosis
- 18 May 2011
- journal article
- research article
- Published by Wiley in Genetic Epidemiology
- Vol. 35 (6), 568-571
- https://doi.org/10.1002/gepi.20592
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosisNature Genetics, 2010
- Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohortEuropean Journal of Neurology, 2010
- Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axonsNature Genetics, 2009
- Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosisNature Genetics, 2008
- Equivalence Testing for Binomial Random VariablesThe American Statistician, 2001
- Statistics notes: Absence of evidence is not evidence of absenceBMJ, 1995
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987